Harvard Bioscience, Inc. (HBIO)
8.24
+0.09
(+1.10%)
USD |
NASDAQ |
Oct 15, 16:00
8.24
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Total Long Term Debt (Quarterly) : 42.61M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.61M |
| March 31, 2026 | 42.57M |
| December 31, 2025 | 42.75M |
| September 30, 2025 | 41.30M |
| June 30, 2025 | 41.86M |
| March 31, 2025 | 43.19M |
| December 31, 2024 | 43.34M |
| September 30, 2024 | 44.56M |
| June 30, 2024 | 40.39M |
| March 31, 2024 | 40.17M |
| December 31, 2023 | 41.36M |
| September 30, 2023 | 43.16M |
| June 30, 2023 | 46.08M |
| March 31, 2023 | 48.99M |
| December 31, 2022 | 52.11M |
| September 30, 2022 | 54.79M |
| June 30, 2022 | 54.29M |
| March 31, 2022 | 55.12M |
| December 31, 2021 | 54.82M |
| September 30, 2021 | 51.93M |
| June 30, 2021 | 50.11M |
| March 31, 2021 | 50.73M |
| December 31, 2020 | 55.49M |
| September 30, 2020 | 51.17M |
| June 30, 2020 | 51.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 56.95M |
| December 31, 2019 | 62.04M |
| September 30, 2019 | 62.66M |
| June 30, 2019 | 63.54M |
| March 31, 2019 | 65.40M |
| December 31, 2018 | 60.80M |
| September 30, 2018 | 61.05M |
| June 30, 2018 | 61.45M |
| March 31, 2018 | 62.98M |
| December 31, 2017 | 11.75M |
| September 30, 2017 | 12.44M |
| June 30, 2017 | 13.20M |
| March 31, 2017 | 13.65M |
| December 31, 2016 | 13.75M |
| September 30, 2016 | 15.04M |
| June 30, 2016 | 16.16M |
| March 31, 2016 | 17.15M |
| December 31, 2015 | 18.90M |
| September 30, 2015 | 20.15M |
| June 30, 2015 | 20.65M |
| March 31, 2015 | 21.90M |
| December 31, 2014 | 21.45M |
| September 30, 2014 | 23.20M |
| June 30, 2014 | 22.25M |
| March 31, 2014 | 23.50M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 3.645B |
| Bio-Rad Laboratories, Inc. | 1.337B |
| Bruker Corp. | 1.825B |
| Danaher Corp. | 26.56B |
| Illumina, Inc. | 2.445B |